December 1 (SeeNews) - Bulgarian drug maker Sopharma [BUL:3JR] said that its consolidated net profit excluding minority interest dropped to 21.9 million levs ($13.4 million/11.2 million euro) in the first nine months of the year from 33.8 million levs in the same period of 2019.